Bailitenheng: The injection Iza-bren is included in the list of breakthrough therapies.

Baili Tianheng announcement, the company's independently developed injection Iza-bren for locally advanced or metastatic urothelial carcinoma patients has been included in the list of breakthrough therapies by the National Medical Products Administration Drug Evaluation Center and has recently been made public. This is the drug's second time receiving breakthrough therapy designation after multiple indications.